AMPK/PI3K/AKT/mTOR経路を標的としたタイプ2糖尿病誘発性腎障害の改善
Nahla Hussien1, Yasmine Gamal Sabry1, Ansam Aly Seif1
1Physiology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Abstract:
This study was conducted to delineate the beneficial effect of targeting AMPK/PI3K/AKT/mTOR pathway on kidney injury associated with type 2 diabetes (T2D) using Nigella sativa (NS). Rats in our experiments were randomly allocated into 3 groups: control, T2D, and T2D-NS-treated group. Samples from different groups were used to assess renal functions, lipid profile, fasting glucose, and insulin resistance. Moreover, RT-qPCR was exploited to detect the expressional pattern of AMPK, PI3K, AKT, mTOR, HIF-1α, and VEGF. In addition, histopathological analysis was conducted using H&E staining. Our data revealed a significant elevation in the blood glucose, insulin, HbA1C, renal function tests, microalbuminuria, as well as marked dyslipidemia that were associated with deleterious histopathological changes in T2D group compared to their matched control. Moreover, there was an increase in the expressional level of PI3K, AKT, mTOR, HIF-1α, and VEGF and downward regulation of AMPK. NS treatment could successfully ameliorate the biochemical and histopathological changes observed in the diabetic group to comparable levels observed in the control group, as it exerted a clear antidiabetic, antihyperlipidemic, and renoprotective effect in T2D.
さらに関連する動画
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
関連する概念動画
PI3K/mTOR/AKT Signaling Pathway
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
cAMP-dependent Protein Kinase Pathways
Chronic Kidney Disease III: Interprofessional Care
